ArticleAntioxidants & redox signaling2016

Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease.

Isabel Lastres-Becker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.